On Thursday, April 18, 2024, U.S. Food and Drug Administration (FDA) Commissioner Robert M. Califf, M.D. appeared before the U.S. Agriculture/FDA Appropriations Subcommittee to present the FDA Fiscal Year (FY) 2025 Presidential Budget request. In response to the budget request, Subcommittee Chairman Harris (R-Maryland) said that, while more reasonable than previous years, the budget request still increases federal spending and ignores the current fiscal environment.
In light of the conversation around FDA’s FY 2025 funding, the Alliance for a Stronger FDA, a stakeholder group committed to advocating for a more effective FDA, has published its “ask” for FY 2025 funding for the agency, calling for a budget authority (BA) appropriation of $3.896 billion for salaries and expenses. This is $214 million more than the Presidential budget request submitted by FDA for FY 2025, and $377 million more than the FY 2024 funding level.